BioPharma Drug Discovery
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The vaccine incorporates five distinct RSV antigens...
November 15, 2022 | News
Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines
Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives fo...
November 15, 2022 | News
Malvern Panalytical and Applied Photophysics announce distribution agreement for Protein Stable’s SUPR-DSF
Malvern Panalytical (Malvern, UK) and Applied Photophysics (Leatherhead, UK) have today announced their commercial agreement for Malvern Panalytical to dis...
November 14, 2022 | News
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...
November 14, 2022 | News
Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China
Merck to offer its first-to-market Blazar ® Rodent Panel for virus testing Reduces biosafety turnaround time by up to 80% Reduces animal ...
November 08, 2022 | News
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met ...
November 07, 2022 | News
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...
November 07, 2022 | News
Ardigen supports JUMP-CP Consortium to transform drug discovery with Cell Painting technology
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cel...
October 28, 2022 | News
Merck Highlights New Data for Evobrutinib
Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...
October 26, 2022 | News
BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference
CPhI WW will be held in Frankfurt, Germany from November 1 to November 3, 2022. The conference will focus on product sustainability and innovation across t...
October 21, 2022 | News
Bexson Biomedical and Stevanato Group Awarded PDA Drug Delivery Innovation Award
At PDA's annual conference in Palm Springs, CA on October 18th, PDA's leadership presented the award to Bexson Biomedical's Sr. VP of D...
October 20, 2022 | News
Kira Pharmaceuticals Announces IND Approval from Chinese NMPA
Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today th...
October 17, 2022 | News
Merck to Support Jacobio Pharma on Clinical Trial of JAB-21822 in Combination with Cetuximab
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer. Jacobio ...
October 13, 2022 | News
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014
Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...
October 10, 2022 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
